Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
Centessa Pharmaceuticals (Nasdaq: CNTA) has announced its participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Centessa Pharmaceuticals (Nasdaq: CNTA) has announced its participation in two upcoming investor conferences. The first event is the Jefferies London Healthcare Conference on November 17, 2022, featuring a fireside chat at 10:55 AM GMT. The second is the Evercore ISI HealthCONx Conference, held virtually on November 30, 2022, at 3:30 PM ET.
Live webcasts and archived recordings will be accessible on the Centessa Pharmaceuticals investor relations website.
Details
News Market Reaction – CNTA
The recorded move for CNTA in the trading session of this news was -0.75%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON and LONDON, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that members of its management team will participate in the following investor conferences:
Event: Jefferies London Healthcare Conference
Date: Thursday, November 17, 2022
Location: London, UK
Fireside Chat: 10:55 AM GMT
Event: Evercore ISI HealthCONx Conference (Virtual)
Date: Wednesday, November 30, 2022
Fireside Chat: 3:30 PM ET
Access to the live webcasts of these events, as well as archived recordings, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations.
About Centessa Pharmaceuticals
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications in rare diseases and immuno-oncology. We operate with the conviction that each one of our programs has the potential to change the current treatment paradigm and establish a new standard of care. For more information, visit www.centessa.com, which does not form part of this release.
Contact:
Kristen K. Sheppard, Esq.
SVP of Investor Relations
investors@centessa.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.